Marimed (MRMD) Share-based Compensation (2011 - 2026)

Marimed (MRMD) has 13 years of Share-based Compensation data on file, last reported at $325000.0 in Q1 2026.

• On a quarterly basis, Share-based Compensation fell 40.59% year-over-year to $325000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 436.1% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 18900.0% from the prior year.
• Share-based Compensation for Q1 2026 stood at $325000.0, down from $422000.0 in the prior quarter.
• Over the last five years, Share-based Compensation for MRMD reached as high as $5.2 million in Q2 2023 and fell as low as -$4.3 million in Q4 2023.
• Historically, Share-based Compensation has averaged $602500.0 across 5 years, with a median of $353500.0 in 2025.
• Across the five-year window, Share-based Compensation jumped 8136.67% in 2022 and tumbled 7393.1% in 2023, its largest moves.
• Year by year, Share-based Compensation stood at -$58000.0 in 2022, then tumbled by 7393.1% to -$4.3 million in 2023, then surged by 82.47% to -$762000.0 in 2024, then surged by 155.38% to $422000.0 in 2025, then declined by 22.99% to $325000.0 in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $325000.0 in Q1 2026, $422000.0 in Q4 2025, and $382000.0 in Q3 2025.